Your email has been successfully added to our mailing list.

×
0.106796116504854 0.106796116504854 0.201941747572815 0.16504854368932 0.16504854368932 0.0679611650485437 0.164854368932039 0.164854368932039
Stock impact report

Interpace Biosciences Announces Collaborative Study with University of North Carolina to Assess the Use BarreGEN® after Ablation of Dysplastic Barrett’s Esophagus

INTERPACE BIOSCIENCES INC (IDXG) 
Last interpace biosciences inc earnings: 11/13 04:40 pm Check Earnings Report
US:NASDAQ Investor Relations: interpacediagnostics.com/investors
Company Research Source: GlobeNewswire
Parsippany, NJ, Jan. 06, 2020 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (Nasdaq: IDXG), a leader in enabling personalized medicine, today announced that the Company’s wholly-owned subsidiary, Interpace Diagnostics has entered into a collaborative study aimed at exploring the potential use of BarreGEN® in patients undergoing radiofrequency ablation (RFA). RFA is typically known as a cancer preventative therapy that either delays or arrests the progression of Barrett’s Esophagus to esophageal cancer. Evidence to date suggests that BarreGEN® may identify non-dysplastic Barrett’s Esophagus patients in need of ablation, making targeted ablation a potentially cost-effective treatment option. This new collaborative study performed in partnership with the University of North Carolina Division of Gastroenterology under the direction of Nick Shaheen, MD MPH, using the BarreGEN® assay developed by Interpace aims to target the potential for molecular changes to predict resistance or relap Show less Read more
Impact Snapshot
Event Time:
IDXG
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for IDXG alerts
Opt-in for
IDXG alerts

from News Quantified
Opt-in for
IDXG alerts

from News Quantified